The largest UK investment in Germany in 2019 in terms of number of employees was by pharmaceutical firm BAP Pharma. The global company, which specializes in the clinical trial supply of comparator drugs, established a state-of-the-art facility in Höchstädt an der Donau in Bavaria last year, creating 200 jobs.
“Germany is the largest pharmaceuticals market in Europe and is home to many key players in the industry,” says BAP Pharma’s managing director Bashir Parkar. “We have seen an increase in business with German companies over the last few years, so one of the main drivers for us was access and proximity to suppliers and customers. The issue of Brexit and the uncertainty surrounding the future access to the European market accelerated our decision-making process. After we had paid an initial visit to the country and seen the opportunities available to us, the decision to set up there became a no-brainer.”